Table 2 Univariate and multivariate analysis for positive-risk disease
Variable | Positive-risk (No. %) | Univariate | Multivariate | |||
|---|---|---|---|---|---|---|
No | Yes | p value | OR | 95% CI | p value | |
Age (year) | 0.08 | |||||
< 50.5 | 22 (9.5%) | 119 (51.5%) | ||||
≥ 50.5 | 7 (3.0%) | 83 (35.9%) | ||||
SCCA (ng/ml) | < 0.001 | 8.972 | 1.908–42.182 | 0.005 | ||
< 2.45 | 27 (12.1%) | 81 (36.2%) | ||||
≥ 2.45 | 2 (0.9%) | 114 (50.9%) | ||||
FIGO stage | < 0.001 | – | – | 0.065 | ||
IA2-IB2 | 21 (9.1%) | 72 (31.2%) | ||||
IIA1-IIA2 | 8 (3.5%) | 130 (56.3%) | ||||
SUVmax | < 0.001 | 2.943 | 1.118–7.746 | 0.029 | ||
< 7.96 | 16 (7.0%) | 28 (12.2%) | ||||
≥ 7.96 | 12 (5.2%) | 174 (75.7%) | ||||
MTV | < 0.001 | – | – | 0.426 | ||
< 20.88 | 24 (10.5%) | 49 (21.4%) | ||||
≥ 20.88 | 4 (1.7%) | 152 (66.4%) | ||||
TLG | < 0.001 | 16.201 | 1.974–132.971 | 0.01 | ||
< 137.40 | 27 (11.8%) | 69 (30.1%) | ||||
≥ 137.40 | 1 (0.4%) | 132 (57.6%) | ||||